Stem Cell Therapy for Heart Failure Conference: TheraVitae CEO Among Researchers Presenting New Findings
Researchers discuss the latest clinical therapies for heart disease using stem cell therapy.
Bangkok (PRWEB) September 16, 2005 -- Dr. Valentin Fulga, CEO of TheraVitae, Ltd., an international biotechnology company and the producer of VesCell, adult stem cell therapy for heart disease was one of several speakers at the conference, Cell Therapy for the Failing Heart." The conference, sponsored by Bangkok Heart Hospital, was held September 14th, at the Bangkok Radisson Hotel.
Topics included Circulating Progenitor Cells and Myoblast transplantation.
Dr. Fulgas talk, entitled Angiogenic cell precursors, a powerful tool to treat cardiovascular disorders" presented the scientific background of blood-borne stem cells and the concepts that led to the development of VesCell, TheraVitaes commercial adult stem cell product used for treating certain types of heart disease. Additionally, Dr. Fulga presented experimental data showing the various effects of the cells and the rationale behind using them in clinical practice.
Invited speakers in addition to Dr. Fulga were:
| | - Dr. Supachai Chaithiraphan (President, Heart Association of Thailand under The Royal Patronage of H.M. the King, President of ASEAN Federation of Cardiology)
- Dr. Kitipan V. Arom (President, The Society of Thoracic Surgeons of Thailand, Deputy Director, Bangkok Heart Hospital)
- Assoc. Professor Dr. Damras Tresukosol (Siriraj Hospital, Mahidol University, Bangkok)
- Dr. Eugene Sim (National University of Singapore)
- Dr. Permyos Ruengsakulrach (Cardiothoracic Surgeon, Bangkok Heart Hospital)
|
TheraVitaes founder, Mr. Don Margolis described the event as, a chance to share, gain, and spread information on autologous adult stem cell treatments." Margolis was also pleased that the conference took place in Thailand, which he calls, the leading country for cardiac-related stem cell therapy."
About Bangkok Heart Hospital
Bangkok Heart Hospital is a leading institution in the treatment of cardiac disorders using several innovative technologies. Bangkok Heart Hospital is currently using TheraVitaes VesCell adult stem cell product to treat cardiomyopathies of various origin in no-option heart patients. Additionally, Bangkok Heart Hospital has engaged in a clinical trial using VesCell in conjunction with Coronary Artery Bypass Surgery (CABG) to treat congestive heart failure.
Bangkok Heart Hospital emerged from the successful Bangkok Heart Institute which was established in 1989 as one of the institutes of Bangkok Hospital. The Bangkok Heart Hospital is the first private heart hospital in Thailand. It aims to provide excellent care for all types of heart disease. A large group of experienced adult & pediatric cardiologists, cardiac surgeons, cardiac anesthesiologists, cardiac rehabilitation physicians and radiologists who have had their subspecialty training and work experience overseas in countries such as the United States, Australia and Japan. Their well-trained and experienced nurses, technicians and paramedical personnel provide 24-hour care for all heart diseases
About VesCell
VesCell consists of a patients own adult stem cells harvested from approximately ½ pint of the patients own blood and is used to treat heart disorders. Once harvested, the cells are differentiated and expanded in vitro at the TheraVitae laboratories in Israel and are ready for implantation in about one week. The cellular product is a viable alternative for patients who either cannot undergo or choose not to undergo the standard revascularization treatments such as Coronary Artery Bypass Grafting (CABG).
About TheraVitae
TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology called VesCell that is currently being used by hospitals in Thailand to treat patients with heart disease. TheraVitae is based in Bangkok, Thailand, Kiryat Weizmann, Israel, and Hong Kong.
For more information, please visit http://www.vescell.com
TheraVitae, Ltd.
36/72 PS Tower, 21/Fl.,
Sukhumvit 21, Klongtoey Nua,
Bangkok 10110
Thailand
# # #
|
